Reverb Therapeutics raised $12 million in a seed round led by Amplitude Ventures to advance its Amplify•R™ platform for treating life-threatening diseases.
Reverb Therapeutics raised $12 million in a seed round led by Amplitude Ventures to advance its Amplify•R™ platform for treating life-threatening diseases.
02/19/25, 12:10 PM
Location
vancouverMoney raised
$12 million
Industry
therapeutics
biotechnology
health care
Round Type
seed
Investors
Seido Capital, In Bc Investment Corp., Finchley Healthcare Ventures, Kd T Ventures, Myeloma Investment Fund, Amplitude Ventures
Reverb Therapeutics announced the closure of a $12 million financing round, with Amplitude Ventures leading the investment. The funding will support the development of its Amplify•R™ platform aimed at modulating cytokine actions to treat cancer and autoimmune diseases.
Company Info
Location
vancouver, british columbia, canada
Additional Info
Reverb Therapeutics is a leader in creating precision medicine by harnessing the body’s immune system and endogenous cytokines. Their Amplify•R™ platform combines bispecific antibody engineering with data-driven modelling to amplify cytokine activity in a tissue-specific manner. This innovative approach aims to avoid the common hurdles associated with cytokine treatments while focusing on cancer and autoimmune diseases. Reverb's technology enables rapid pre-clinical testing and is scalable across multiple therapeutic areas.